“ Therapeutic Monoclonal Antibodies: ScFv Patents As a Marker of a New Class of Potential Biopharmaceuticals ”. 2011. Brazilian Journal of Pharmaceutical Sciences 47 (1): 31-38. https://doi.org/10.1590/S1984-82502011000100005.